Kanwal Raghav

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Papers

Driven by 48 papers — median percentile 0. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Phase 2 study of pembrolizumab in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000347

N/A

4.0DataRank · unranked

131 citations

Funda Meric‐Bernstam, Bettzy Stephen, Daniel D. Karp, Joud Hajjar, Jordi Rodon Ahnert +35 more

Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004822

N/A

1.4DataRank · unranked

44 citations

Bettzy Stephen, Daniel D. Karp, Sarina A. Piha‐Paul, David S. Hong, D Jain +10 more

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

EBioMedicine(2020)10.1016/j.ebiom.2020.103030

N/A

0.737DataRank · unranked

135 citations

Ziwei Pan, Sandeep Namburi, Andrew Pattison, Atara Posner, Shiva Balachander +12 more

Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States

Cancer(2022)10.1002/cncr.34223

N/A

0.659DataRank · unranked

13 citations

Hop S. Tran Cao, Jean‐Nicolas Vauthey, Gohar Manzar, Kelsey L. Corrigan, Kanwal Raghav +12 more

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0331

N/A

0.648DataRank · unranked

74 citations

Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu-Chin Fu +29 more

YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial

Nature Medicine(2025)10.1038/s41591-025-04029-3

N/A

0.578DataRank · unranked

46 citations

David J. Kwiatkowski, Ibiayi Dagogo-Jack, Michael Offin, Marjorie G. Zauderer, Robert A. Kratzke +13 more

Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial

JCO Precision Oncology(2021)10.1200/po.20.00372

N/A

0.574DataRank · unranked

45 citations

Shivaani Kummar, Nancy Moore, Larry Rubinstein, Yingdong Zhao, P. Mickey Williams +20 more

Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

Pancreatology(2020)10.1016/j.pan.2020.01.005

N/A

0.561DataRank · unranked

41 citations

Jane E. Rogers, Kenneth R. Hess, Robert A. Wolff, Gauri R. Varadhachary, Milind Javle +7 more

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

The Oncologist(2024)10.1093/oncolo/oyad338

N/A

0.510DataRank · unranked

29 citations

Binghe Xu, Ecaterina E. Dumbrava, Siqing Fu, Daniel D. Karp, Funda Meric‐Bernstam +20 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002

N/A

0.477DataRank · unranked

23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162

N/A

0.464DataRank · unranked

21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi -NT in Patients with Advanced Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3952

N/A

0.330DataRank · unranked

8 citations

Filip Jankú, Siqing Fu, Ecaterina E. Dumbrava, David S. Hong, Daniel D. Karp +20 more

Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-471

N/A

0.241DataRank · unranked

4 citations

Bryan K. Kee, Michael J. Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson +6 more

Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations

ESMO Open(2025)10.1016/j.esmoop.2025.104136

N/A

0.241DataRank · unranked

4 citations

Chieh Tseng, Hai T. Tran, Aung Naing, Ecaterina E. Dumbrava, DD Karp +9 more

PRESSING Need of Precision Care in HER2-Positive Colorectal Cancer: The ELEPHANT in the Room

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2580

N/A

0.165DataRank · unranked

2 citations

Jonathan M. Loree, Scott Kopetz, Kanwal Raghav

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8603

N/A

0.104DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Panos Savvides, Liza C. Villaruz, Patrick M. Forde +12 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps8598

N/A

0.104DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Vinicius Ernani, Patrick M. Forde, Liza C. Villaruz +12 more

Comprehensive genomic profiling of malignant peritoneal mesothelioma (MPeM) reveals key genomic alterations (GAs) distinct from malignant pleural mesothelioma (MPM).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8557

N/A

0.104DataRank · unranked

1 citations

Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu-Chin Fu, Anaís Malpica +13 more

Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.13819

N/A

0DataRank · unranked

12 citations

Joseph Abi Jaoude, Roshal R. Patel, Ramez Kouzy, Timothy A. Lin, Brian De +11 more

Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.226

N/A

0DataRank · unranked

8 citations

Fadl A. Zeineddine, Abdelrahman Yousef, Julia Dansby, Michael G. White, Michael J. Overman +7 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

Goblet cell tumors of the appendix: Clinical and molecular features.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.223

N/A

0DataRank · unranked

0 citations

Zahra Alavi Naini, Mohammad A. Zeineddine, Saikat Chowdhury, Julia Dansby, Aditya More +6 more

Utility of tumor marker levels in predicting survival of patients with appendiceal adenocarcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.221

N/A

0DataRank · unranked

0 citations

Aditya More, Mohammad A. Zeineddine, Saikat Chowdhury, Yue Gu, Julia Dansby +7 more

A prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.163

N/A

0DataRank · unranked

0 citations

Abdelrahman Yousef, Fadl A. Zeineddine, Mohammad A. Zeineddine, Karen A. Beaty, Lisa C. Scofield +15 more

Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary

Journal of Gastrointestinal Cancer(2023)10.1007/s12029-023-00922-7

N/A

0DataRank · unranked

0 citations

Vincent Bernard, Jaewon J. Lee, Bret M. Stephens, Vittorio Branchi, Kanwal Raghav +4 more

Data from Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

(2023)10.1158/1078-0432.c.6528374.v1

N/A

0DataRank · unranked

0 citations

Amber M. Johnson, Ecaterina E. Dumbrava, Kanwal Raghav, Kavitha Balaji, Michelle Bhatt +4 more

Data from Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

(2023)10.1158/2159-8290.c.6549433.v1

N/A

0DataRank · unranked

0 citations

Suyu Liu, Michael J. Overman, Anneleis F. Willett, Mark Knafl, Szu‐Chin Fu +29 more

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1

N/A

0DataRank · unranked

0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

Prognostic and predictive significance of pre- and post-operative plasma tumor markers in patients with appendiceal adenocarcinoma undergoing cytoreductive surgery: Insights from a single-center study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3539

N/A

0DataRank · unranked

0 citations

Mahmoud Yousef, Mohammad A. Zeineddine, Ichiaki Ito, Saikat Chowdhury, Yue Gu +15 more

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s282062

N/A

0DataRank · unranked

47 citations

Sweet Ping Ng, Amy Liu, Santiago Avila, Randa Tao, Emma B. Holliday +19 more

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0019

N/A

0DataRank · unranked

11 citations

Mohammad A. Zeineddine, Betul Beyza Gunes, Andrew J. Pellatt, Mark Knafl, Haifeng Zhu +12 more

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

medRxiv(2024)10.1101/2024.09.11.24313334

N/A

0DataRank · unranked

5 citations

Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Ahmed Amer +26 more

Mutational and co-mutational landscape of early onset colorectal cancer

Biomarkers(2025)10.1080/1354750x.2024.2447089

N/A

0DataRank · unranked

24 citations

Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G. White, John Paul Shen +14 more

Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1024

N/A

0DataRank · unranked

43 citations

Benny Johnson, Laveniya Kugathasan, Van K. Morris, Kanwal Raghav, Lucas Swanson +9 more

Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer

British Journal of Cancer(2020)10.1038/s41416-020-1015-3

N/A

0DataRank · unranked

48 citations

John Paul Shen, Alexandre A. Jácome, Jennifer L. Guerra, Christopher P. Scally, Melissa W. Taggart +7 more

Consensus guideline for the management of colorectal cancer with peritoneal metastases

Cancer(2025)10.1002/cncr.35869

N/A

0DataRank · unranked

5 citations

Varun Bansal, Michael M. Wach, Neal Bhutiani, Frederick A. Godley, Jane Wang +19 more

Consensus guideline for the management of peritoneal mesothelioma

Cancer(2025)10.1002/cncr.35868

N/A

0DataRank · unranked

2 citations

Sarah G. Wilkins, Varun Bansal, David Su, Jorge L. Gomez‐Mayorga, Kiran K. Turaga +11 more

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

npj Systems Biology and Applications(2025)10.1038/s41540-025-00616-9

N/A

0DataRank · unranked

0 citations

Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Ahmed Amer +26 more

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa034

N/A

0DataRank · unranked

114 citations

Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari +4 more

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520

N/A

0DataRank · unranked

9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

Circulating tumor DNA dynamics on front-line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: A biomarker analysis for acquired genomic alterations in CALGB/SWOG 80405 (Alliance) randomized trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.193

N/A

0DataRank · unranked

4 citations

Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Ryan Sun, Heinz‐Josef Lenz +2 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592

N/A

0DataRank · unranked

0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more

Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0340

N/A

0DataRank · unranked

15 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad095

N/A

0DataRank · unranked

21 citations

Aakash Tushar Shah, Honey V. Reddi, Priyadarsini Dasari, James T. Topham, Hyunsoo Hwang +16 more

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases

Liver Cancer(2023)10.1159/000530134

N/A

0DataRank · unranked

13 citations

Rituraj Upadhyay, Kaiping Liao, Tiffany Kumala, Christopher Shi, Grace Dodoo +24 more

Kanwal Raghav

Indexed papers

Top data-sharing exemplar

Papers